Calvin Sternick

Stock Analyst at JP Morgan

(2.78)
# 1,901
Out of 4,711 analysts
18
Total ratings
41.67%
Success rate
11.08%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Dec 3, 2024
Maintains: Overweight
Price Target: $117$120
Current: $91.31
Upside: +31.42%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $59.58
Upside: +34.27%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $13.01
Upside: +107.53%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $180.11
Upside: +1.05%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $129.46
Upside: -37.43%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $294.73
Upside: +33.00%